Pediatric Hematology/Oncology and ImmunopathologyPediatric Hematology/Oncology and ImmunopathologyВопросы гематологии/онкологии и иммунопатологии в педиатрии1726-17082414-9314Fund Doctors, Innovations, Science for Children71710.24287/1726-1708-2023-22-4-73-78ORIGINAL ARTICLESОРИГИНАЛЬНЫЕ СТАТЬИComparison between serum nephrin and microalbuminuria as biomarkers for sickle cell nephropathyComparison between serum nephrin and microalbuminuria as biomarkers for sickle cell nephropathyEl-HawyMahmoud AhmedEl-HawyMahmoud Ahmed
Egypt

Menoufia

Mahmodelhawy18@yahoo.comEl-MistekawySamar Elsayed Tawfik
Egypt

Menoufia

dr_naboelkhair@yahoo.comAboelkhairNoran Talaat
Egypt

Menoufia

Menoufia

zeinab_sabri@yahoo.comhttps://orcid.org/0000-0002-1270-8175AbouzounaZeinab Sabri
Egypt

Zeinab Sabri Abouzouna, MD, Lecturer in Pediatrics, Department of Pediatrics

Shebin El Kom, 32511 Menoufia

zeinab_sabri@yahoo.comMenoufia UniversityEgyptian Ministry of HealthMenoufia University2012202322473780205202320062023Copyright ©; 2023, «D. Rogachev NMRCPHOI»Copyright ©; 2023, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России2023«D. Rogachev NMRCPHOI»ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава Россииhttps://creativecommons.org/licenses/by/4.0https://hemoncim.com/jour/article/view/717

Sickle cell anemia is the most common monogenic blood disorder. The most common genotype is homozygous hemoglobin SS. Damage to red blood cells occurs due to changes in shape and function of the hemoglobin molecule inside it. This results in hemolytic anemia and the blockade of small blood vessels, which lead to vaso-occlusion and end organ failure. Sickle cell disease significantly alters renal structure and function and causes diverse renal diseases. To evaluate the validity of serum nephrin as a biomarker of sickle nephropathy and compare its sensitivity versus urinary microalbuminuria in the early detection of sickle cell nephropathy. This case control study was conducted on sixty patients suffering from sickle cell disease, 10 of them were diagnosed as sickle nephropathy, in addition to sixty apparently healthy children as a control group. Laboratory tests were hemoglobin electrophoresis, urinary microalbumin, serum ferritin, urea and creatinine. The glomerular filtration rate was estimated and serum nephrin was measured using enzymelinked immunosorbent assay. Among children with sickle cell anemia, 16.6% (10 patients) had sickle nephropathy diagnosed with elevated kidney function and low glomerular filtration rate. Liver and kidney function were significantly higher in cases with nephropathy than cases without nephropathy, while glomerular filtration rate was significantly lower in cases with nephropathy than cases without nephropathy. Serum nephrin was significantly higher in patients with nephropathy than patients without nephropathy versus non-significant difference regarding microalbuminuria level. The cutoff point for nephrin to diagnose sickle cell nephropathy was > 13 ng/mL versus 29.5 mg/dL for urinary microalbumin. Serum nephrin could be a valuable biomarker in early diagnosis of nephropathy in patients with sickle cell anemia.

Sickle cell anemia is the most common monogenic blood disorder. The most common genotype is homozygous hemoglobin SS. Damage to red blood cells occurs due to changes in shape and function of the hemoglobin molecule inside it. This results in hemolytic anemia and the blockade of small blood vessels, which lead to vaso-occlusion and end organ failure. Sickle cell disease significantly alters renal structure and function and causes diverse renal diseases. To evaluate the validity of serum nephrin as a biomarker of sickle nephropathy and compare its sensitivity versus urinary microalbuminuria in the early detection of sickle cell nephropathy. This case control study was conducted on sixty patients suffering from sickle cell disease, 10 of them were diagnosed as sickle nephropathy, in addition to sixty apparently healthy children as a control group. Laboratory tests were hemoglobin electrophoresis, urinary microalbumin, serum ferritin, urea and creatinine. The glomerular filtration rate was estimated and serum nephrin was measured using enzymelinked immunosorbent assay. Among children with sickle cell anemia, 16.6% (10 patients) had sickle nephropathy diagnosed with elevated kidney function and low glomerular filtration rate. Liver and kidney function were significantly higher in cases with nephropathy than cases without nephropathy, while glomerular filtration rate was significantly lower in cases with nephropathy than cases without nephropathy. Serum nephrin was significantly higher in patients with nephropathy than patients without nephropathy versus non-significant difference regarding microalbuminuria level. The cutoff point for nephrin to diagnose sickle cell nephropathy was > 13 ng/mL versus 29.5 mg/dL for urinary microalbumin. Serum nephrin could be a valuable biomarker in early diagnosis of nephropathy in patients with sickle cell anemia.

sickle cell anemiaserum nephrinmicroalbuminsickle nephropathysickle cell anemiaserum nephrinmicroalbuminsickle nephropathyNeumayr LD, Hoppe CC, Brown C. Sickle cell disease: current treatment and emerging therapies. Am J Manag Care. 2019 Nov 1;25(18):335-43.Neumayr L.D., Hoppe C.C., Brown C. Sickle cell disease: current treatment and emerging therapies. Am J Manag Care 2019; 25 (18): 335–43.Ansari J, Moufarrej YE, Pawlinski R, Gavins FN. Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease. Expert review of hematology. 2018 Jan 2;11(1):45-55.Ansari J., Moufarrej Y.E., Pawlinski R., Gavins F.N. Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease. Exp Rev Hematol 2018; 11 (1): 45–55.El-Beshlawy A, Youssry I. Prevention of hemoglobinopathies in Egypt. Hemoglobin. 2009 Jan 1; 33(sup1):S14-20.El-Beshlawy A., Youssry I. Prevention of hemoglobinopathies in Egypt. Hemoglobin 2009; 33 (suppl 1): S14–20.Olaniran KO, Eneanya ND, Nigwekar SU, Vela-Parada XF, Achebe MM, Sharma A, Thadhani RI. Sickle cell nephropathy in the pediatric population. Blood purification. 2019;47(1-3):205-13.Olaniran K.O., Eneanya N.D., Nigwekar S.U., Vela-Parada X.F., Achebe M.M., et al. Sickle cell nephropathy in the pediatric population. Blood Purif 2019; 47 (1–3): 205–13.Tal R. The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis. Biology of reproduction. 2012;87(6):134,1-8Tal R. The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis. Biol Reprod 2012; 87 (6): 134.Maier-Redelsperger M, Noguchi CT, de Montalembert M, Rodgers GP, Schechter AN, Gourbil A, et al., Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian Prospective Study on Sickle Cell Disease.1994;84(9):3182–3188.Maier-Redelsperger M., Noguchi C.T., de Montalembert M., Rodgers G.P., Schechter A.N., Gourbil A., et al., Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian Prospective Study on Sickle Cell Disease. Blood 1994; 84 (9): 3182–8.Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood, The Journal of the American Society of Hematology. 2010; 115(17):3447–3452.Quinn C.T., Rogers Z.R., McCavit T.L., Buchanan G.R. Improved survival of children and adolescents with sickle cell disease. Blood 2010; 115 (17): 3447–52.Bartolucci P, Habibi A, Stehlé T, di Liberto G, Rakotoson MG, Gellen-Dautremer J, et al. Six months of hydroxyurea reduces albuminuria in patients with sickle cell disease. J Am Soc Nephrol. 2016; 27(6):1847–1853.Bartolucci P., Habibi A., Stehlé T., di Liberto G., Rakotoson M.G., Gellen-Dautremer J., et al. Six months of hydroxyurea reduces albuminuria in patients with sickle cell disease. J Am Soc Nephrol 2016; 27 (6): 1847–53.Brett Heimlich J, Speed JS, O'Connor PM, Pollock JS, Townes TM, Meiler SE, et al. Endothelin‐1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species. British journal of pharmacology. 2016; 173(2):386-95.Brett Heimlich J., Speed J.S., O'Connor P.M., Pollock J.S., Townes T.M., Meiler S.E., et al. Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species. Br J Pharmacol 2016; 173 (2): 386–95.Thompson J,Reid M, Hambleton I and Serjeant GR. Albuminuria and renal function in homozygous sickle cell disease: observation from cohort study. Arch Intern Med .2007; 167:701708.Thompson J., Reid M., Hambleton I., Serjeant G.R. Albuminuria and renal function in homozygous sickle cell disease: observation from cohort study. Arch Intern Med 2007; 167: 701–8.McKie KT, Hanevold CD, Hernandez C, Waller JL, Ortiz L, McKie KM. Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease. Journal of pediatric hematology/oncology. 2007; 29(3):140-4.McKie K.T., Hanevold C.D., Hernandez C., Waller J.L., Ortiz L., McKie K.M. Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease. J Pediatric Hematol Oncol 2007; 29 (3): 140–4.Heimlich J, Chipoka G, Elsherif L, David E, Ellis G, Kamthunzi P et al. Nephrin as a Biomarker of Sickle Cell Glomerulopathy in Malawi. Pediatric Blood Cancer. 2018 Jun; 65(6): e26993.Heimlich J., Chipoka G., Elsherif L., David E., Ellis G., Kamthunzi P., et al. Nephrin as a Biomarker of Sickle Cell Glomerulopathy in Malawi. Pediatr Blood Cancer 2018; 65 (6): e26993.Sundd P, Gladwin MT, Novelli EM. Pathophysiology of sickle cell disease. Annual Review of Pathology. Mechanisms of Disease.2019; 14:263-292.Sundd P., Gladwin M.T., Novelli E.M. Pathophysiology of sickle cell disease. Annu Rev Pathol 2019; 14: 263–92.Youssry I , Makar S, Fawzy R, Wilson M, AbdAllah G , Fathy E et al. Novel marker for the detection of sickle cell nephropathy: soluble FMS-like tyrosine kinase-1 (sFLT-1). Pediatric Nephrology. 2015; 30(12):2163-2168.Youssry I., Makar S., Fawzy R., Wilson M., AbdAllah G., Fathy E., et al. Novel marker for the detection of sickle cell nephropathy: soluble FMS-like tyrosine kinase-1 (sFLT1). Pediatr Nephrol 2015; 30 (12): 2163–8.Moraleda C, Aguilar R, Quintó L, Nhampossa T, Renom M, Nhabomba A, et al.. Anaemia in hospitalised preschool children from a rural area in Mozambique: a case control study in search for etiological agents. BMC Pediatric. 2017; 17(1):63.Moraleda C., Aguilar R., Quintó L., Nhampossa T., Renom M., Nhabomba A., et al. Anaemia in hospitalised preschool children from a rural area in Mozambique: a case control study in search for etiological agents. BMC Pediatric 2017; 17 (1): 63.Zaini RG. Sickle-cell anemia and consanguinity among the Saudi Arabian population. Arch Med. 2016; 8(3):3-15.Zaini R.G. Sickle-cell anemia and consanguinity among the Saudi Arabian population. Arch Med 2016; 8 (3): 3–15.Hamad AL-Mijallib S, Adilc H, Nasird A, Abdelaald DE, Haroone BE, Abd Elfataha R. The Role of Consanguinity in the frequency of Sickle cell anaemia in North Kordofan state. 2012; 12(1):1-13.Hamad AL-Mijallib S., Adilc H., Nasird A., Abdelaald D.E., Haroone B.E., Abd Elfataha R. The Role of Consanguinity in the frequency of Sickle cell anaemia in North Kordofan state. 2012; 12 (1): 1–13.Nandanwar RA, Kamd NY. Sickle cell disease affects physical growth. Int J Pharm Bio Sci. 2013; 4:784–789.Nandanwar R.A., Kamd N.Y. Sickle cell disease affects physical growth. Int J Pharm Bio Sci 2013; 4: 784–9.Rodrigues L, Costa FF, Saad ST. High levels of neopterin and interleukin-3 in sickle cell disease patients. Journal of Clinical Laboratory Analysis.2006; 20(3):75–79.Rodrigues L., Costa F.F., Saad S.T. High levels of neopterin and interleukin-3 in sickle cell disease patients. J Clin Lab Anal 2006; 20 (3): 75–9.Akodu SO, Diaku-Akinwumi IN and Njokanma OF .Obesity - Does It Occur in Nigerian Children with Sickle Cell Anemia. Pediatric Hematology and Oncology.2012; 29(4):358–364.Akodu S.O., Diaku-Akinwumi I.N., Njokanma O.F. Obesity – Does It Occur in Nigerian Children with Sickle Cell Anemia. Pediatr Hematol Oncol 2012; 29 (4): 358–64Isaza-López MC, Rojas-Rosas LF, Echavarría-Ospina L, Serna-Higuita LM. Caracterización de las complicaciones renales en pacientes con anemia de células falciformes. Revista chilena de pediatría. 2020; 91(1):51-7.Isaza-López M.C., Rojas-Rosas L.F., Echavarría-Ospina L., Serna-Higuita L.M. Caracterización de las complicaciones renales en pacientes con anemia de células falciformes. Rev Chil Pediatr 2020; 91 (1): 51–7.Geard A, Pule GD, Chetcha Chemegni B, Ngo Bitoungui VJ, Kengne AP, Chimusa ER, Wonkam A. Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon. British journal of haematology. 2017; 178(4):629-39.Geard A., Pule G.D., Chetcha Chemegni B., Ngo Bitoungui V.J., Kengne A.P., Chimusa E.R., Wonkam A. Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon. Br J Haematol 2017; 178 (4): 629–39.Nding’uri WW. Sickle cell nephropathy among children and adolescents with sickle cell disease at Bungoma County Referral Hospital (Doctoral dissertation, Moi University. 2021; 21(75);1486-1493.Nding’uri W.W. Sickle cell nephropathy among children and adolescents with sickle cell disease at Bungoma County Referral Hospital (Doctoral dissertation, Moi University). 2021; 21 (75): 1486–93.Benneh-Akwasi Kuma A, Owusu-Ansah AT, Ampomah MA, Sey F, Olayemi E, Nouraie M, et al. Prevalence of relative systemic hypertension in adults with sickle cell disease in Ghana. PLoS One. 2018; 13(1):e0190347.Benneh-Akwasi Kuma A., Owusu-Ansah A.T., Ampomah M.A., Sey F., Olayemi E., Nouraie M., et al. Prevalence of relative systemic hypertension in adults with sickle cell disease in Ghana. PLoS One 2018; 13 (1): e0190347.Kadhim DA, Al-Dujaili AN. Estimation of nephrin level in sickle cell anemia patients associated with nephropathy. InAIP Conference Proceedings. AIP Publishing LLC.. 2020; 2290(1):20040.Kadhim D.A., Al-Dujaili A.N. Estimation of nephrin level in sickle cell anemia patients associated with nephropathy. InAIP Conference Proceedings. AIP Publishing LLC 2020; 2290 (1): 20040.Sofue T, Kiyomoto H, Kobori H, Urushihara M, Nishijima Y, Kaifu K, et al. Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats. American journal of hypertension. 2012; 25(5):604-11.Sofue T., Kiyomoto H., Kobori H., Urushihara M., Nishijima Y., Kaifu K., et al. Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats. Am J Hypertens 2012; 25 (5): 604–11.Petrica L, Ursoniu S, Gadalean F, Vlad A, Gluhovschi G, Dumitrascu S, et al. Urinary podocyte-associated mRNA levels correlate with proximal tubule dysfunction in early diabetic nephropathy of type 2 diabetes mellitus. Diabetol Metab Syndr. 2017; 9: 31.Petrica L., Ursoniu S., Gadalean F., Vlad A., Gluhovschi G., Dumitrascu S., et al. Urinary podocyte-associated mRNA levels correlate with proximal tubule dysfunction in early diabetic nephropathy of type 2 diabetes mellitus. Diabetol Metab Syndr 2017; 9: 31.Becton LJ, Kalpatthi RV, Rackoff E, Disco D, Orak JK, Jackson SM et al. Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease. Pediatric Nephrology. 2010; 25(8):1505–1511.Becton L.J., Kalpatthi R.V., Rackoff E., Disco D., Orak J.K., Jackson S.M., et al. Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease. Pediatr Nephrol 2010; 25 (8): 1505–11.Alvarez O, Lopez-Mitnik G, Zilleruelo G. Short‐term follow‐up of patients with sickle cell disease and albuminuria. Pediatric Blood & Cancer. 2008; 50(6):1236–1239.Alvarez O., Lopez-Mitnik G., Zilleruelo G. Short-term follow-up of patients with sickle cell disease and albuminuria. Pediatr Blood Cancer 2008; 50 (6): 1236–9.